Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Subarachnoid Hemorrhage | 22 | 2021 | 1033 | 2.620 |
Why?
|
Hydrocephalus | 4 | 2021 | 764 | 1.320 |
Why?
|
Endarterectomy, Carotid | 5 | 2022 | 555 | 0.820 |
Why?
|
Vasospasm, Intracranial | 9 | 2011 | 215 | 0.690 |
Why?
|
Ventriculostomy | 2 | 2018 | 131 | 0.680 |
Why?
|
Cerebrospinal Fluid Shunts | 2 | 2019 | 195 | 0.670 |
Why?
|
Drainage | 2 | 2021 | 1156 | 0.580 |
Why?
|
Cerebrovascular Disorders | 8 | 2012 | 1474 | 0.540 |
Why?
|
Intracranial Thrombosis | 2 | 2015 | 108 | 0.530 |
Why?
|
Hematoma, Epidural, Spinal | 1 | 2016 | 37 | 0.510 |
Why?
|
Intracranial Hypertension | 1 | 2018 | 193 | 0.510 |
Why?
|
Magnetic Resonance Angiography | 7 | 2016 | 1432 | 0.420 |
Why?
|
Brain Injuries | 2 | 2019 | 2053 | 0.410 |
Why?
|
Consciousness Disorders | 1 | 2016 | 441 | 0.390 |
Why?
|
Cerebrovascular Circulation | 9 | 2016 | 2727 | 0.390 |
Why?
|
Carotid Stenosis | 4 | 2022 | 860 | 0.370 |
Why?
|
Ischemic Attack, Transient | 5 | 2022 | 882 | 0.360 |
Why?
|
Intracranial Embolism | 2 | 2001 | 189 | 0.320 |
Why?
|
Disease Management | 1 | 2019 | 2507 | 0.320 |
Why?
|
Nicardipine | 2 | 2008 | 60 | 0.310 |
Why?
|
Evidence-Based Medicine | 1 | 2019 | 3687 | 0.290 |
Why?
|
Brain Ischemia | 10 | 2012 | 3049 | 0.250 |
Why?
|
Stroke | 12 | 2022 | 9756 | 0.250 |
Why?
|
Nerve Net | 1 | 2016 | 2288 | 0.230 |
Why?
|
Sodium Chloride | 1 | 2006 | 587 | 0.230 |
Why?
|
Hypothermia, Induced | 2 | 2006 | 756 | 0.220 |
Why?
|
Intensive Care Units | 1 | 2017 | 3744 | 0.220 |
Why?
|
Intracranial Aneurysm | 5 | 2017 | 1285 | 0.220 |
Why?
|
Lupus Erythematosus, Systemic | 1 | 2016 | 2163 | 0.210 |
Why?
|
Hyperglycemia | 2 | 2009 | 1376 | 0.210 |
Why?
|
Cerebral Arteries | 3 | 2002 | 490 | 0.200 |
Why?
|
Fibrinolytic Agents | 5 | 2022 | 2084 | 0.200 |
Why?
|
Endovascular Procedures | 1 | 2015 | 2181 | 0.190 |
Why?
|
Cerebral Angiography | 3 | 2005 | 1281 | 0.190 |
Why?
|
Thrombolytic Therapy | 5 | 2015 | 2065 | 0.190 |
Why?
|
Weaning | 1 | 2021 | 103 | 0.190 |
Why?
|
Phenylephrine | 2 | 2001 | 293 | 0.180 |
Why?
|
Fever | 2 | 2006 | 1618 | 0.180 |
Why?
|
Ventriculoperitoneal Shunt | 2 | 2021 | 188 | 0.180 |
Why?
|
Calcium Channel Blockers | 1 | 2004 | 694 | 0.180 |
Why?
|
Embolism, Cholesterol | 1 | 2000 | 32 | 0.180 |
Why?
|
Cerebral Infarction | 7 | 2005 | 983 | 0.180 |
Why?
|
Sagittal Sinus Thrombosis | 1 | 1999 | 11 | 0.180 |
Why?
|
Carotid Artery, Internal | 1 | 2003 | 445 | 0.170 |
Why?
|
Dantrolene | 2 | 2011 | 26 | 0.170 |
Why?
|
Liver Cirrhosis, Alcoholic | 1 | 1999 | 64 | 0.170 |
Why?
|
APACHE | 1 | 2000 | 267 | 0.170 |
Why?
|
Tomography, X-Ray Computed | 14 | 2015 | 20556 | 0.170 |
Why?
|
Muscle Relaxants, Central | 2 | 2011 | 93 | 0.160 |
Why?
|
Intracranial Hemorrhages | 3 | 2022 | 822 | 0.160 |
Why?
|
Treatment Outcome | 14 | 2022 | 64651 | 0.160 |
Why?
|
Cerebral Veins | 1 | 1999 | 157 | 0.150 |
Why?
|
Intracranial Embolism and Thrombosis | 1 | 1998 | 144 | 0.150 |
Why?
|
Clinical Competence | 1 | 2013 | 4793 | 0.140 |
Why?
|
Prospective Studies | 13 | 2022 | 54415 | 0.140 |
Why?
|
Tissue Plasminogen Activator | 3 | 2010 | 1164 | 0.140 |
Why?
|
Purpura, Thrombotic Thrombocytopenic | 1 | 1998 | 130 | 0.130 |
Why?
|
Length of Stay | 3 | 2021 | 6422 | 0.130 |
Why?
|
Hypoglycemic Agents | 1 | 2009 | 3081 | 0.130 |
Why?
|
Aged | 39 | 2016 | 169235 | 0.120 |
Why?
|
Cyclohexanecarboxylic Acids | 1 | 1996 | 140 | 0.120 |
Why?
|
Vasoconstrictor Agents | 2 | 2002 | 654 | 0.120 |
Why?
|
Blood Glucose | 2 | 2009 | 6391 | 0.120 |
Why?
|
Magnetic Resonance Imaging | 16 | 2006 | 36423 | 0.120 |
Why?
|
Spin Labels | 1 | 2016 | 337 | 0.120 |
Why?
|
Embolization, Therapeutic | 2 | 2004 | 1418 | 0.120 |
Why?
|
Phospholipases A | 2 | 1995 | 204 | 0.120 |
Why?
|
Acetates | 1 | 1996 | 321 | 0.120 |
Why?
|
Amines | 1 | 1996 | 281 | 0.120 |
Why?
|
Humans | 64 | 2022 | 761423 | 0.120 |
Why?
|
Insulin | 1 | 2009 | 6602 | 0.120 |
Why?
|
Thromboembolism | 1 | 2001 | 996 | 0.120 |
Why?
|
Male | 51 | 2016 | 360736 | 0.110 |
Why?
|
Herpes Zoster | 1 | 1996 | 253 | 0.110 |
Why?
|
Retrospective Studies | 17 | 2022 | 80582 | 0.110 |
Why?
|
Blood Pressure | 4 | 2012 | 8487 | 0.110 |
Why?
|
Middle Aged | 39 | 2016 | 220826 | 0.110 |
Why?
|
Female | 51 | 2016 | 392581 | 0.100 |
Why?
|
Patient Admission | 1 | 2000 | 1367 | 0.100 |
Why?
|
Odds Ratio | 4 | 2013 | 9645 | 0.100 |
Why?
|
Pilot Projects | 5 | 2016 | 8633 | 0.090 |
Why?
|
Postoperative Complications | 4 | 2012 | 15650 | 0.090 |
Why?
|
Microsomes | 1 | 1991 | 251 | 0.090 |
Why?
|
Adult | 30 | 2021 | 221148 | 0.090 |
Why?
|
Acute Disease | 9 | 2006 | 7238 | 0.090 |
Why?
|
Neurotoxins | 1 | 1991 | 240 | 0.090 |
Why?
|
Isoenzymes | 2 | 1995 | 1688 | 0.090 |
Why?
|
Glutamates | 1 | 1991 | 389 | 0.090 |
Why?
|
Aged, 80 and over | 15 | 2015 | 58956 | 0.090 |
Why?
|
Middle Cerebral Artery | 2 | 2008 | 275 | 0.080 |
Why?
|
gamma-Aminobutyric Acid | 1 | 1996 | 1140 | 0.080 |
Why?
|
Neuralgia | 1 | 1996 | 614 | 0.080 |
Why?
|
Risk Adjustment | 1 | 2013 | 600 | 0.080 |
Why?
|
Brain | 11 | 2004 | 27107 | 0.080 |
Why?
|
Infusions, Intra-Arterial | 2 | 2008 | 222 | 0.080 |
Why?
|
Arterial Occlusive Diseases | 2 | 2005 | 748 | 0.070 |
Why?
|
Lipid Peroxides | 2 | 1998 | 74 | 0.070 |
Why?
|
Hospital Mortality | 2 | 2010 | 5291 | 0.070 |
Why?
|
Heat-Shock Proteins | 1 | 1991 | 796 | 0.070 |
Why?
|
Ultrasonography, Doppler, Transcranial | 2 | 2011 | 281 | 0.070 |
Why?
|
Critical Care | 1 | 2000 | 2697 | 0.070 |
Why?
|
Pelvis | 2 | 2003 | 732 | 0.070 |
Why?
|
Diffusion | 2 | 1999 | 814 | 0.070 |
Why?
|
Nicotine | 1 | 2011 | 680 | 0.070 |
Why?
|
Headache | 2 | 2012 | 1256 | 0.070 |
Why?
|
Perfusion | 3 | 2003 | 1373 | 0.070 |
Why?
|
Monitoring, Intraoperative | 1 | 2012 | 942 | 0.070 |
Why?
|
Simvastatin | 1 | 2008 | 346 | 0.060 |
Why?
|
Infusions, Intravenous | 2 | 2011 | 2218 | 0.060 |
Why?
|
Extravasation of Diagnostic and Therapeutic Materials | 1 | 2006 | 101 | 0.060 |
Why?
|
Databases, Factual | 2 | 2012 | 7956 | 0.060 |
Why?
|
Vasoconstriction | 2 | 2011 | 592 | 0.060 |
Why?
|
Cerebral Hemorrhage | 2 | 2006 | 2656 | 0.060 |
Why?
|
Vasodilation | 1 | 2008 | 961 | 0.060 |
Why?
|
Radiographic Image Enhancement | 1 | 2008 | 876 | 0.060 |
Why?
|
Intracranial Arteriosclerosis | 1 | 2005 | 138 | 0.060 |
Why?
|
Embolism, Paradoxical | 1 | 2003 | 54 | 0.060 |
Why?
|
Bartonella Infections | 1 | 2003 | 21 | 0.050 |
Why?
|
Cerebral Cortex | 3 | 1998 | 5776 | 0.050 |
Why?
|
Quality Assurance, Health Care | 1 | 2013 | 2169 | 0.050 |
Why?
|
Logistic Models | 4 | 2012 | 13255 | 0.050 |
Why?
|
Basilar Artery | 2 | 2005 | 205 | 0.050 |
Why?
|
Nervous System Diseases | 1 | 2012 | 1666 | 0.050 |
Why?
|
Pregnancy Complications, Cardiovascular | 1 | 2006 | 515 | 0.050 |
Why?
|
Serotonin Receptor Agonists | 1 | 2002 | 151 | 0.050 |
Why?
|
Hypertension | 1 | 2001 | 8542 | 0.050 |
Why?
|
Risk Factors | 9 | 2022 | 74167 | 0.050 |
Why?
|
Stents | 1 | 2012 | 3179 | 0.050 |
Why?
|
Cholesterol Esters | 2 | 1998 | 74 | 0.040 |
Why?
|
Cytosol | 2 | 1995 | 888 | 0.040 |
Why?
|
Rehabilitation, Vocational | 1 | 2000 | 81 | 0.040 |
Why?
|
Craniotomy | 1 | 2004 | 741 | 0.040 |
Why?
|
Treatment Failure | 1 | 2006 | 2642 | 0.040 |
Why?
|
Predictive Value of Tests | 7 | 2012 | 15262 | 0.040 |
Why?
|
Secondary Prevention | 1 | 2006 | 1474 | 0.040 |
Why?
|
Seizures | 1 | 2012 | 2957 | 0.040 |
Why?
|
Cohort Studies | 4 | 2012 | 41446 | 0.040 |
Why?
|
Smoking Cessation | 1 | 2011 | 2056 | 0.040 |
Why?
|
Angiography | 1 | 2005 | 1599 | 0.040 |
Why?
|
Veins | 1 | 2003 | 768 | 0.040 |
Why?
|
Catheterization, Peripheral | 1 | 2003 | 342 | 0.040 |
Why?
|
Brain Damage, Chronic | 1 | 2000 | 267 | 0.040 |
Why?
|
Data Interpretation, Statistical | 1 | 2009 | 2691 | 0.040 |
Why?
|
Risk Assessment | 5 | 2012 | 23990 | 0.040 |
Why?
|
Encephalitis | 1 | 2003 | 438 | 0.040 |
Why?
|
Catheterization | 1 | 2004 | 1432 | 0.040 |
Why?
|
Myocardial Reperfusion | 1 | 2000 | 338 | 0.040 |
Why?
|
Phlebography | 1 | 1999 | 326 | 0.040 |
Why?
|
Systole | 1 | 2000 | 937 | 0.040 |
Why?
|
Electroencephalography | 2 | 2012 | 6224 | 0.040 |
Why?
|
Differential Threshold | 1 | 1997 | 80 | 0.040 |
Why?
|
Glutamic Acid | 2 | 1995 | 1176 | 0.040 |
Why?
|
Mitochondria | 1 | 1991 | 3623 | 0.040 |
Why?
|
Heparin, Low-Molecular-Weight | 1 | 1999 | 344 | 0.040 |
Why?
|
Thrombophlebitis | 1 | 1998 | 289 | 0.040 |
Why?
|
Status Epilepticus | 1 | 2003 | 460 | 0.040 |
Why?
|
Nuclear Family | 1 | 1998 | 313 | 0.030 |
Why?
|
Radioisotope Teletherapy | 1 | 1996 | 15 | 0.030 |
Why?
|
Bulbar Palsy, Progressive | 1 | 1996 | 9 | 0.030 |
Why?
|
Cranial Nerve Injuries | 1 | 1996 | 28 | 0.030 |
Why?
|
Cobalt Radioisotopes | 1 | 1996 | 75 | 0.030 |
Why?
|
Registries | 1 | 2012 | 8223 | 0.030 |
Why?
|
Blood Coagulation Disorders | 1 | 1999 | 350 | 0.030 |
Why?
|
Autopsy | 1 | 2000 | 1007 | 0.030 |
Why?
|
Hydrocephalus, Normal Pressure | 1 | 1997 | 100 | 0.030 |
Why?
|
Rupture, Spontaneous | 1 | 1997 | 362 | 0.030 |
Why?
|
Age Factors | 1 | 2012 | 18400 | 0.030 |
Why?
|
Phospholipases A2 | 2 | 1995 | 197 | 0.030 |
Why?
|
Aortic Aneurysm | 1 | 2000 | 648 | 0.030 |
Why?
|
Chromatography, Gel | 2 | 1995 | 646 | 0.030 |
Why?
|
Intracranial Pressure | 1 | 1997 | 324 | 0.030 |
Why?
|
Renal Insufficiency | 1 | 2000 | 809 | 0.030 |
Why?
|
Venous Thrombosis | 1 | 2003 | 1303 | 0.030 |
Why?
|
Diffusion Magnetic Resonance Imaging | 2 | 2004 | 2790 | 0.030 |
Why?
|
Heart Diseases | 3 | 2004 | 2785 | 0.030 |
Why?
|
Nasopharyngeal Neoplasms | 1 | 1996 | 290 | 0.030 |
Why?
|
Activities of Daily Living | 2 | 2000 | 2421 | 0.030 |
Why?
|
Neurons | 2 | 1995 | 9462 | 0.030 |
Why?
|
Prognosis | 5 | 2006 | 29620 | 0.030 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2008 | 3244 | 0.030 |
Why?
|
Fatal Outcome | 1 | 1998 | 1834 | 0.030 |
Why?
|
Family Health | 1 | 1998 | 1257 | 0.030 |
Why?
|
Safety | 1 | 1997 | 1150 | 0.030 |
Why?
|
Electroconvulsive Therapy | 1 | 1998 | 500 | 0.030 |
Why?
|
Constriction | 1 | 2012 | 171 | 0.030 |
Why?
|
Cause of Death | 2 | 2000 | 3684 | 0.030 |
Why?
|
Hot Temperature | 2 | 2004 | 1440 | 0.020 |
Why?
|
Ultrasonography, Doppler, Duplex | 1 | 2012 | 198 | 0.020 |
Why?
|
Dactinomycin | 1 | 1991 | 304 | 0.020 |
Why?
|
Gerbillinae | 1 | 1991 | 87 | 0.020 |
Why?
|
Aneurysm, Ruptured | 1 | 1997 | 463 | 0.020 |
Why?
|
Cycloheximide | 1 | 1991 | 343 | 0.020 |
Why?
|
Reperfusion Injury | 1 | 1998 | 1023 | 0.020 |
Why?
|
Hydrogen-Ion Concentration | 2 | 1995 | 2498 | 0.020 |
Why?
|
L-Lactate Dehydrogenase | 1 | 1991 | 411 | 0.020 |
Why?
|
Reperfusion | 1 | 1991 | 271 | 0.020 |
Why?
|
Blotting, Northern | 1 | 1991 | 1545 | 0.020 |
Why?
|
Platelet Aggregation Inhibitors | 1 | 2022 | 2751 | 0.020 |
Why?
|
Hepatitis C | 1 | 1999 | 1584 | 0.020 |
Why?
|
Ventricular Dysfunction, Left | 1 | 2000 | 2119 | 0.020 |
Why?
|
Anticonvulsants | 2 | 1996 | 1906 | 0.020 |
Why?
|
Electrocardiography | 2 | 2000 | 6384 | 0.020 |
Why?
|
Radiation Injuries | 1 | 1996 | 1189 | 0.020 |
Why?
|
Boston | 2 | 2012 | 9330 | 0.020 |
Why?
|
Myocardial Infarction | 2 | 2000 | 11458 | 0.020 |
Why?
|
Myocardial Ischemia | 1 | 1999 | 2110 | 0.020 |
Why?
|
Liver Transplantation | 1 | 1999 | 2333 | 0.020 |
Why?
|
Chromatography, High Pressure Liquid | 1 | 1991 | 1540 | 0.020 |
Why?
|
Survival Analysis | 1 | 2000 | 10089 | 0.020 |
Why?
|
Feasibility Studies | 2 | 2011 | 5246 | 0.020 |
Why?
|
Hematoma, Subdural, Intracranial | 1 | 2006 | 30 | 0.020 |
Why?
|
Anticoagulants | 1 | 2022 | 4813 | 0.020 |
Why?
|
Causality | 2 | 2003 | 1243 | 0.020 |
Why?
|
Sensitivity and Specificity | 4 | 2003 | 14664 | 0.020 |
Why?
|
Shivering | 1 | 2004 | 12 | 0.020 |
Why?
|
Paresis | 1 | 2006 | 176 | 0.020 |
Why?
|
Regional Blood Flow | 1 | 2008 | 1496 | 0.020 |
Why?
|
Meperidine | 1 | 2004 | 38 | 0.020 |
Why?
|
Neurologic Examination | 2 | 1999 | 916 | 0.010 |
Why?
|
Carcinoma | 1 | 1996 | 2330 | 0.010 |
Why?
|
Echocardiography | 3 | 2003 | 4991 | 0.010 |
Why?
|
Multivariate Analysis | 2 | 2012 | 12058 | 0.010 |
Why?
|
Protein Biosynthesis | 1 | 1991 | 2114 | 0.010 |
Why?
|
Ascorbic Acid | 2 | 1998 | 655 | 0.010 |
Why?
|
Skin Temperature | 1 | 2004 | 96 | 0.010 |
Why?
|
Vasodilator Agents | 1 | 2008 | 973 | 0.010 |
Why?
|
Buspirone | 1 | 2004 | 81 | 0.010 |
Why?
|
Chi-Square Distribution | 1 | 2010 | 3418 | 0.010 |
Why?
|
Severity of Illness Index | 3 | 2012 | 15838 | 0.010 |
Why?
|
Kinetics | 1 | 1991 | 6374 | 0.010 |
Why?
|
Maternal Age | 1 | 2006 | 809 | 0.010 |
Why?
|
Comorbidity | 2 | 2010 | 10498 | 0.010 |
Why?
|
Epilepsy | 1 | 1998 | 3290 | 0.010 |
Why?
|
Injections, Intravenous | 1 | 2005 | 1380 | 0.010 |
Why?
|
Contrast Media | 2 | 2008 | 5311 | 0.010 |
Why?
|
Dementia | 1 | 1997 | 2686 | 0.010 |
Why?
|
Incidence | 1 | 2001 | 21341 | 0.010 |
Why?
|
Ephedrine | 1 | 2002 | 52 | 0.010 |
Why?
|
Academic Medical Centers | 1 | 2012 | 2760 | 0.010 |
Why?
|
RNA | 1 | 1991 | 2723 | 0.010 |
Why?
|
Cell Survival | 1 | 1991 | 5790 | 0.010 |
Why?
|
Neoplasms | 1 | 2010 | 22164 | 0.010 |
Why?
|
Vena Cava, Inferior | 1 | 2004 | 459 | 0.010 |
Why?
|
Body Temperature | 1 | 2004 | 782 | 0.010 |
Why?
|
Heart Septal Defects, Atrial | 1 | 2003 | 460 | 0.010 |
Why?
|
Hematoma | 1 | 2005 | 768 | 0.010 |
Why?
|
Time Factors | 5 | 2002 | 39975 | 0.010 |
Why?
|
Algorithms | 1 | 2001 | 14026 | 0.010 |
Why?
|
Follow-Up Studies | 4 | 2003 | 39117 | 0.010 |
Why?
|
Cells, Cultured | 2 | 1995 | 18964 | 0.010 |
Why?
|
Brain Stem Infarctions | 1 | 1999 | 31 | 0.010 |
Why?
|
Cerebral Arterial Diseases | 1 | 1999 | 82 | 0.010 |
Why?
|
Rats | 2 | 1995 | 23742 | 0.010 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2011 | 10766 | 0.010 |
Why?
|
Hemodynamics | 2 | 2000 | 4168 | 0.010 |
Why?
|
Quality of Life | 1 | 2000 | 13361 | 0.010 |
Why?
|
Single-Blind Method | 1 | 2002 | 1571 | 0.010 |
Why?
|
Transcription, Genetic | 1 | 1991 | 7595 | 0.010 |
Why?
|
Social Adjustment | 1 | 2000 | 632 | 0.010 |
Why?
|
Observer Variation | 1 | 2003 | 2605 | 0.010 |
Why?
|
Blood Volume | 1 | 1999 | 548 | 0.010 |
Why?
|
Gestational Age | 1 | 2006 | 3576 | 0.010 |
Why?
|
Diagnosis, Differential | 2 | 2006 | 12970 | 0.010 |
Why?
|
Creutzfeldt-Jakob Syndrome | 1 | 1997 | 93 | 0.010 |
Why?
|
Recombinant Proteins | 1 | 2006 | 6532 | 0.010 |
Why?
|
Neck Muscles | 1 | 1996 | 100 | 0.010 |
Why?
|
Cranial Nerves | 1 | 1996 | 98 | 0.010 |
Why?
|
Calcimycin | 1 | 1995 | 213 | 0.010 |
Why?
|
Ubiquinone | 1 | 1997 | 183 | 0.010 |
Why?
|
Survival Rate | 2 | 2000 | 12720 | 0.010 |
Why?
|
Pneumonia, Aspiration | 1 | 1996 | 145 | 0.010 |
Why?
|
Dogs | 1 | 2000 | 3839 | 0.010 |
Why?
|
Pregnancy Outcome | 1 | 2006 | 2920 | 0.010 |
Why?
|
Speech Disorders | 1 | 1996 | 180 | 0.010 |
Why?
|
Ultrasonography | 1 | 2008 | 5970 | 0.010 |
Why?
|
Neck Injuries | 1 | 1996 | 160 | 0.010 |
Why?
|
Cachexia | 1 | 1996 | 202 | 0.010 |
Why?
|
Echo-Planar Imaging | 1 | 1999 | 663 | 0.010 |
Why?
|
Tetradecanoylphorbol Acetate | 1 | 1995 | 817 | 0.010 |
Why?
|
Lung Diseases | 1 | 2004 | 1909 | 0.010 |
Why?
|
Double-Blind Method | 1 | 2008 | 12330 | 0.010 |
Why?
|
Animals | 4 | 2000 | 168441 | 0.010 |
Why?
|
Tomography, Emission-Computed | 1 | 1997 | 1122 | 0.010 |
Why?
|
ROC Curve | 1 | 2001 | 3580 | 0.010 |
Why?
|
Disability Evaluation | 1 | 2000 | 1836 | 0.010 |
Why?
|
Vitamin E | 1 | 1997 | 872 | 0.010 |
Why?
|
Disease Progression | 2 | 1999 | 13502 | 0.010 |
Why?
|
Electromyography | 1 | 1996 | 1393 | 0.010 |
Why?
|
Risk | 1 | 2003 | 9612 | 0.010 |
Why?
|
Recovery of Function | 1 | 2001 | 2977 | 0.010 |
Why?
|
Oxidation-Reduction | 1 | 1997 | 2230 | 0.010 |
Why?
|
Uric Acid | 1 | 1997 | 807 | 0.010 |
Why?
|
Deglutition Disorders | 1 | 1996 | 625 | 0.010 |
Why?
|
Enteral Nutrition | 1 | 1996 | 792 | 0.010 |
Why?
|
Enzyme Activation | 1 | 1995 | 3597 | 0.010 |
Why?
|
Arrhythmias, Cardiac | 1 | 1999 | 2246 | 0.000 |
Why?
|
Antioxidants | 1 | 1997 | 1669 | 0.000 |
Why?
|
Dyspnea | 1 | 1996 | 1347 | 0.000 |
Why?
|
Combined Modality Therapy | 1 | 2000 | 8529 | 0.000 |
Why?
|
Heart | 1 | 2000 | 4405 | 0.000 |
Why?
|
Models, Statistical | 1 | 2001 | 5077 | 0.000 |
Why?
|
Pregnancy | 1 | 2006 | 29862 | 0.000 |
Why?
|
Reproducibility of Results | 1 | 2002 | 20093 | 0.000 |
Why?
|
Calcium | 1 | 1995 | 5727 | 0.000 |
Why?
|
Disease Models, Animal | 1 | 2000 | 18247 | 0.000 |
Why?
|
Alzheimer Disease | 1 | 1997 | 8596 | 0.000 |
Why?
|
United States | 1 | 2003 | 72339 | 0.000 |
Why?
|
Adolescent | 1 | 2003 | 88313 | 0.000 |
Why?
|
Heart Failure | 1 | 1999 | 11674 | 0.000 |
Why?
|